CTAS Form 4: Director awarded 503 shares and 1,694 options
Rhea-AI Filing Summary
Cintas Corporation (CTAS) filed a Form 4 for director Karen L. Carnahan. On 10/29/2025, she received 503 restricted shares at $0 under the company’s 2016 Amended and Restated Equity and Incentive Compensation Plan. These restricted shares cliff vest on the first anniversary of the grant date.
She was also granted stock options to purchase 1,694 shares at an exercise price of $183.90, expiring on 10/29/2035; the option cliff vests on the first anniversary of the grant date. Following these transactions, she beneficially owns 25,256 shares directly.
Positive
- None.
Negative
- None.
Insights
Routine director equity grants; neutral governance event.
Cintas reported standard annual equity awards to a director: 503 restricted shares at $0 and options for 1,694 shares at an exercise price of $183.90, both granted on 10/29/2025 under the 2016 plan. The restricted shares and options each cliff vest after one year, aligning director incentives with shareholders.
The filing lists a post‑transaction direct holding of 25,256 shares. As a non-cash grant with typical vesting, the immediate financial impact is limited and depends on future vesting and any option exercises.
Key details are the option expiration on 10/29/2035 and the one-year vesting. Actual effects on share count occur upon vesting or exercise, subject to plan terms.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,694 | $0.00 | -- |
| Grant/Award | Common Stock | 503 | $0.00 | -- |
Footnotes (1)
- Restricted shares granted pursuant to Cintas Corporation's 2016 Amended and Restated Equity and Incentive Compensation Plan. These shares cliff vest on the first anniversary of the grant date. Options granted pursuant to Cintas Corporation's 2016 Amended and Restated Equity and Incentive Compensation Plan. The option cliff vests on the first anniversary of the grant date.
FAQ
What did CTAS report on this Form 4 for director Karen L. Carnahan?
When do the CTAS director’s awards vest?
What is the exercise price and expiration for the CTAS options?
Under what plan were the CTAS equity awards granted?